Zobrazeno 1 - 10
of 115
pro vyhledávání: '"R. Carosio"'
Autor:
A. Boutros, R. Carosio, D. Campanella, F. Spagnolo, B. Banelli, A. Morabito, M.P. Pistillo, E. Croce, F. Cecchi, P. Pronzato, P. Queirolo, E. Raposio, V. Fontana, E.T. Tanda
Publikováno v:
Immuno-Oncology and Technology, Vol 20, Iss , Pp 100408- (2023)
Background: Despite having revolutionized the treatment paradigm for advanced melanoma, not all patients benefit from immune checkpoint inhibitor therapy. To date, there are no predictive biomarkers for response or the occurrence of immune-related ad
Externí odkaz:
https://doaj.org/article/5f6042a2cc5041439f7d2b2d81fb1fc3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A. Boutros, R. Carosio, D. Campanella, F. Spagnolo, B. Banelli, A. Morabito, M.P. Pistillo, E. Croce, F. Cecchi, P. Pronzato, P. Queirolo, V. Fontana, E.T. Tanda
Publikováno v:
Immuno-Oncology and Technology. 16:100129
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Fenretinide-polyvinylalcohol Conjugates: New Systems Allowing Fenretinide Intravenous Administration
Autor:
Roberto Gotti, Paolo G. Montaldo, Valentina Bergamante, Isabella Orienti, Michele Cilli, R. Carosio, Guendalina Zuccari
Publikováno v:
Biomacromolecules. 8:3258-3262
N-(4-hydroxyphenyl)retinamide (fenretinide, 4-HPR) has been shown to be active toward many tumors without appreciable side effects. However its in vitro activity does not match a correspondent efficacy in vivo. The main reason is that the drug's hydr
Autor:
Isabella Orienti, Franca Formelli, Salvatore Mangraviti, Paolo G. Montaldo, Laura Emionite, R. Carosio, Elena Cavadini, Emanuela Ognio, Guendalina Zuccari, Vito Pistoia
Publikováno v:
Journal of Pharmacy and Pharmacology. 64:228-236
Objectives The major limitation to successful chemotherapy of neuroblastoma (NB) is the toxicity and the poor bioavailability of traditional drugs. Methods We synthesised an amphiphilic dextrin derivative (DX-OL) able to host fenretinide (4-HPR) by c
Publikováno v:
Drug Delivery. 16:389-398
This study relates to the preparation of a series of amphiphilic dextrins and their evaluation as complexing agents for anti-tumor hydrophobic drugs such as fenretinide, paclitaxel, etoposide, and camptothecin. The amphiphilic dextrins were obtained
Autor:
Domenico Ribatti, Annalisa Pezzolo, Vito Pistoia, Beatrice Nico, Chiara Brignole, R. Carosio, Fabio Pastorino, Mirco Ponzoni, Federica Piccardi, Michele Cilli, Daniela Di Paolo, Monica Loi, Gabriella Pagnan, Danilo Marimpietri, Luis J. V. Galietta
Publikováno v:
Clinical Cancer Research. 15:1199-1209
Purpose: The proteasome inhibitor bortezomib inhibited cell growth and angiogenesis in neuroblastoma. Bortezomib has been shown to induce synergistic activity when combined with other antineoplastic agents. Here we have investigated the antitumor act
Publikováno v:
Biomacromolecules. 6:2875-2880
A series of poly(vinyl alcohol) amphiphilic derivatives have been prepared to obtain polymeric aggregates in aqueous phase holding thermodynamic instability. The aim was to evaluate their ability to interact with tumor cells eliciting selective cytot
Publikováno v:
Journal of Controlled Release. 103:369-380
All-trans-retinoic acid (ATRA) is now included in many antitumor therapeutic schemes for the treatment of acute promyelocytic leukaemia, Kaposi's sarcoma, head and neck squamous cell carcinoma, ovarian carcinoma, bladder cancer and neuroblastoma. Unf